SCHEMBL193992

SCHEMBL193992

O=Cc1ccccc1C#Cc1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.50
ALDH1A1 P00352 4/20 0.50
MEN1 O00255 3/20 0.50
MAPT P10636 3/20 0.50
NPC1 O15118 2/20 0.50
KDM4E B2RXH2 2/20 0.50
CYP1A2 P05177 2/20 0.50
CYP3A4 P08684 2/20 0.50
CYP2C9 P11712 2/20 0.50
HPGD P15428 2/20 0.50
CYP2C19 P33261 2/20 0.50
HSD17B10 Q99714 2/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
APP P05067 1/20 0.50
LMNA P02545 3/20 0.48
TDP1 Q9NUW8 2/20 0.48
THRB P10828 1/20 0.48
BLM P54132 1/20 0.48
CA12 O43570 2/20 0.47
CA2 P00918 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31587369 0.94 MEN1 (0.50) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL29880146 0.88 KMT2A (0.48) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL15896014 0.85 ALDH1A1 (0.47) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL28544000 0.85 TDP1 (0.41) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL31050960 0.85 KMT2A (0.44) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL29639055 0.83 ERN1 (0.48) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL10623779 0.83 APP (0.50) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL10620408 0.82 APP (0.48) KMT2AALDH1A1MEN1MAPTNPC1
SCHEMBL9428752 0.81 CYP3A4 (0.43) KMT2AALDH1A1MEN1MAPTKDM4E
SCHEMBL28538274 0.81 KCNH2 (0.45) KMT2AMEN1CYP2C9LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117903053-A Synthesis method and application of diaryl azepine compound 河南工业大学 2024-04-19 CN claimed
CN-112778261-B Method for synthesizing isocoumarin derivatives under catalysis of silver and application of isocoumarin derivatives 山东师范大学 2022-08-23 CN claimed
CN-112778261-A Method for synthesizing isocoumarin derivatives under catalysis of silver and application of isocoumarin derivatives 山东师范大学 2021-05-11 CN claimed
CN-116510786-B Binuclear gold catalyst and preparation method and application thereof 中山大学 2025-03-25 CN disclosed
CN-118908943-A Preparation method of indolone-substituted isocoumarin compound 内蒙古大学 2024-11-08 CN disclosed
CN-117903135-A Method for preparing fullerene pyrrolidine tetrahydroisoquinoline based on participation of o-styryl benzaldehyde 湖北大学 2024-04-19 CN disclosed
CN-117903053-A Synthesis method and application of diaryl azepine compound 河南工业大学 2024-04-19 CN disclosed
US-20230399329-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-12-14 US disclosed
US-20230399329-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER LT MATERIALS CO., LTD. (KR) 2023-12-14 US disclosed
CN-116510786-A Binuclear gold catalyst and preparation method and application thereof 中山大学 2023-08-01 CN disclosed
CN-110204533-B Preparation method of 4- (isochromen-1-yl) isoquinoline derivative 曲阜师范大学 2023-01-03 CN disclosed
US-20080188380-A1 PHOTOLABILE COMPOUND, OLIGOMER PROBE ARRAY AND SUBSTRATE FOR OLIGOMER PROBE ARRAY CONTAINING THE SAME, AND MANUFACTURING METHOD OF THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-08-07 US disclosed
US-20080188380-A1 PHOTOLABILE COMPOUND, OLIGOMER PROBE ARRAY AND SUBSTRATE FOR OLIGOMER PROBE ARRAY CONTAINING THE SAME, AND MANUFACTURING METHOD OF THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2008-08-07 US disclosed
EP-1756081-A1 1,1'-(1,2-ETHYNEDIYL)BIS-BENZENE DERIVATIVES AS PTP 1-B INHIBITORS Applied Research Systems ARS Holding N.V. (AN) 2007-02-28 EP disclosed
EP-1680107-A1 SUBSTITUTED OXADIAZOLIDINEDIONES ALS PAI-1 INHIBITORS Wyeth (US) 2006-07-19 EP disclosed
CN-1777577-A Antibacterial agent CHIRON CORP (US) 2006-05-24 CN disclosed
WO-2005097773-A1 1,1’-(1,2-ETHYNEDIYL)BIS-BENZENE DERIVATIVES AS PTP 1-B INHIBITORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-10-20 WO disclosed
WO-2005030203-A1 SUBSTITUTED OXADIAZOLIDINEDIONES ALS PAI-1 INHIBITORS WYETH (US) 2005-04-07 WO disclosed
EP-0279921-A2 Phenylacetylene-substituted schiff's base momomers and electroconductive polymers National Starch and Chemical Investment Holding Corporation (US) 1988-08-31 EP disclosed
US-4730032-A MOLDING MATERIALS NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1988-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230399329-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR FORMING ORGANIC LAYER CRY1, ORC3, ODC1 KMT2A 1517/4885ALDH1A1 45/4885MEN1 463/4885
US-20080188380-A1 PHOTOLABILE COMPOUND, OLIGOMER PROBE ARRAY AND SUBSTRATE FOR OLIGOMER PROBE ARRAY CONTAINING THE SAME, AND MANUFACTURING METHOD OF THE SAME APBA1, APP, PPOX KMT2A 4135/4885ALDH1A1 2534/4885MEN1 3213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.